PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays

Published:2021-01-18 Issue:7 Volume:40 Page:2763-2769
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Mecoli C. A.^ORCID,Gutierrez-Alamillo L.,Yang Q.,Sampedro M.,Woods A.,Hummers L. K.,Wigley F.,Shah A. A.,Casciola-Rosen L.

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Chresanthe Staurulakis Memorial Discovery Fund

Donald B. and Dorothy L. Stabler Foundation

Johns Hopkins inHealth Precision Medicine Initiative

Jerome L Greene Foundation

Scleroderma Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05586-x.pdf

Reference11 articles.

1. Mecoli CA, Casciola-Rosen L (2018) An update on autoantibodies in scleroderma. Curr Opin Rheumatol 30(6):548–553

2. Mecoli CA, Adler BL, Yang Q, Rosen A, Casciola-Rosen L, Shah AA (2020) Cancer in Systemic Sclerosis: analysis of antibodies against components of the Th/To Complex. Arthritis Rheum

3. Medsger TA Jr et al (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 Suppl 29):S42–S46

4. Cottrell TR, Wise RA, Wigley FM, Boin F (2014) The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis 73(6):1060–1066

5. Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37(9):2429–2437

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course;Arthritis & Rheumatology;2023-11-27

2. The Autoantibody Array Assay: A Novel Autoantibody Detection Method;Diagnostics;2023-09-13

3. Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients;Open Access Rheumatology: Research and Reviews;2023-04

4. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population;Arthritis & Rheumatology;2023-02-16

5. Scleroderma autoantibodies in guiding monitoring and treatment decisions;Current Opinion in Rheumatology;2022-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3